🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Cancer Treatment Support Services Market
Generative AI Data Center Market
Global Oligonucleotide CDMO Market Growth (Status and Outlook) 2025-2031
Oct 2025
Information and Communication Technology
Pages: 156
LPI16584
The global Oligonucleotide CDMO market size is predicted to grow from US$ 1370 million in 2025 to US$ 2847 million in 2031; it is expected to grow at a CAGR of 13.0% from 2025 to 2031.
An Oligonucleotide CDMO (Contract Development and Manufacturing Organization) specializes in providing outsourced services related to the development and manufacturing of oligonucleotides. Oligonucleotides are short DNA or RNA molecules used for a variety of applications, including in genetic research, diagnostics, and therapeutics. These organizations are key players in the biopharmaceutical industry, helping companies bring oligonucleotide-based products from the research stage to commercialization.
United States market for Oligonucleotide CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oligonucleotide CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oligonucleotide CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oligonucleotide CDMO players cover Agilent, ST Pharm, Bachem, BioSpring, Creative Biogene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information) newest research report, the Oligonucleotide CDMO Industry Forecast looks at past sales and reviews total world Oligonucleotide CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide CDMO sales for 2025 through 2031. With Oligonucleotide CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide CDMO industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oligonucleotide CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
APIs and Intermediates
FDF
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.
Agilent
ST Pharm
Bachem
BioSpring
Creative Biogene
Sylentis
Ajinomoto Bio-Pharma
EUROAPI
Veliter
PolyPeptide Group
CordenPharma
Thermofischer
Bio Basic
Genscript
Cytiva
ScinoPharm
CBL
Piramal Pharma
CPC Scientific
Eurogentec
Cambrex
WuXi STA
📘 Frequently Asked Questions
1. What is the market size of Global Oligonucleotide CDMO Market?
Answer: The Global Oligonucleotide CDMO Market size was estimated at USD 370 million in 2025 to US$ 2847 in 2024 and is expected to reach USD XX million in 2034.
2. Which regions are analyzed in the Global Oligonucleotide CDMO Market report?
Answer: The Global Oligonucleotide CDMO Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global Oligonucleotide CDMO Market?
Answer: The Global Oligonucleotide CDMO Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global Oligonucleotide CDMO Market?
Answer: Yes, the Global Oligonucleotide CDMO Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global Oligonucleotide CDMO Market?
Answer: Yes, Global Oligonucleotide CDMO Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global Oligonucleotide CDMO Market report?
Answer: Yes, Global Oligonucleotide CDMO Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global Oligonucleotide CDMO Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🎁 This Month Only: Flat $1000 OFF
Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
- Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
- Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
- 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
- Instant Savings:Enjoy a flat $1000 OFF on every report.
- Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
- Tailored Insights:Customized research that fits your industry and specific goals.
📄 Available License Types
